Impaired absorption of insulin aspart from lipohypertrophic injection sites

Diabetes Care. 2005 Aug;28(8):2025-7. doi: 10.2337/diacare.28.8.2025.
No abstract available

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose / metabolism
  • Body Mass Index
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 1 / metabolism
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / pharmacokinetics
  • Injections, Subcutaneous / adverse effects*
  • Insulin / administration & dosage
  • Insulin / analogs & derivatives*
  • Insulin / blood
  • Insulin / pharmacokinetics
  • Insulin Aspart
  • Lipodystrophy / etiology*
  • Male
  • Middle Aged
  • Skin Absorption

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • Insulin Aspart